# Vitamin D: What the Evidence Says
Canonical: https://www.migaku.app/guides/vitamin-d-evidence-review
Category: evidence-review
Summary: Vitamin D has 3 source documents in the current Migaku evidence database. The strongest available sources in this first pass are government public health, so 
Last reviewed: 2026-05-20
Reviewed by: Migaku Evidence Review
# Vitamin D: What the Evidence Says

## Quick Answer

Vitamin D has 3 source documents in the current Migaku evidence database. The strongest available sources in this first pass are government public health, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 government public health, 1 narrative review, 1 research article.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Vitamin D | government public health | 2 | 2024-09-25 | 398781 |
| Vitamin D and exercise in obesity: a neurovascular–muscle axis | narrative review | 3 | 2026-03-12 | 10.3389/fnut.2026.1750915 |
| Sunscreen, vitamin D and skin of colour | research article | 4 | 2026-04-07 | 10.18773/austprescr.2026.009 |

## What The Sources Report

- For babies younger than 12 months, cow's milk is not recommended because it may put your baby at risk for intestinal bleeding. [CENTERS FOR DISEASE CONTROL AND PREVENTION (2024); evidence level 2]
- What vitamin D does Vitamin D helps your child build strong bones and prevent rickets. [CENTERS FOR DISEASE CONTROL AND PREVENTION (2024); evidence level 2]
- A primary characteristic of obesity is the presence of chronic low-grade systemic inflammation, predominantly instigated by hypertrophied adipocytes and aberrant immune cell infiltration, particularly involving M1-polarized macrophages, which collectively foster increased production of cytokines. [Zheng Xiaoxia (2026); evidence level 3]
- Furthermore, the metabolic and vascular derangements associated with obesity have repercussions that extend to the central nervous system, might contribute to neurocognitive decline, compromised neurovascular integrity, and an augmented susceptibility to dementia. [Zheng Xiaoxia (2026); evidence level 3]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

CDC material can support public-health framing, but it should not be used as product endorsement. For vitamin D, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Bottom Line For Readers

For vitamin d, this knowledge-base sample includes at least one stronger evidence source. One representative source-reported claim is: "For babies younger than 12 months, cow's milk is not recommended because it may put your baby at risk for intestinal bleeding." The safest editorial posture is to distinguish deficiency, testing, sun exposure, supplementation, and population-specific needs.

## Evidence Strength

The current evidence set includes 3 unique source documents. 1 source is level 1-2 in this system, while 2 sources are lower-level, indirect, narrative, or early-stage evidence. Treat this as a structured reading guide rather than a final clinical guideline.

## What This Means In Practice

- Separate vitamin D deficiency from general supplementation for already-sufficient adults.
- Mention that testing, baseline status, dose, age, skin exposure, geography, and medical conditions change interpretation.
- Avoid using vitamin D evidence as a broad promise for immune, mood, or performance outcomes without topic-specific sources.

## What The Evidence Does Not Prove

- It does not prove that everyone benefits from supplementation regardless of baseline level.
- It does not replace testing or clinician guidance for deficiency, osteoporosis risk, pregnancy, kidney disease, or malabsorption.

## Editorial Use Cases

This page is most useful as a citation hub for answer-first pages about vitamin d. It can support cautious explainers, comparison sections, safety notes, and evidence tables. It should not be used alone to rank products, promise outcomes, or replace condition-specific clinical guidance.

## Limits Of This First Pass

This deep evidence page is still generated from a bounded knowledge-base sample. It should be reviewed by a human editor before being used for high-stakes decisions or product-ranking claims.

## References

- CENTERS FOR DISEASE CONTROL AND PREVENTION (2024). Vitamin D. License: Public domain unless otherwise marked. https://www.cdc.gov/infant-toddler-nutrition/vitamins-minerals/vitamin-d.html
- Zheng Xiaoxia (2026). Vitamin D and exercise in obesity: a neurovascular–muscle axis. DOI: 10.3389/fnut.2026.1750915. PMCID: PMC13017884. PMID: 41909035. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13017884/
- Sunscreen, vitamin D and skin of colour (2026). Sunscreen, vitamin D and skin of colour. DOI: 10.18773/austprescr.2026.009. PMCID: PMC13095494. PMID: 42022259. License: https://creativecommons.org/licenses/by-nc-nd/4.0/. https://pmc.ncbi.nlm.nih.gov/articles/PMC13095494/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.